Results for "late-stage analysis"

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

Editorial Wire details the confirmed facts, context, and next steps surrounding Novo's next-generation obesity drug shows 25% weight loss in women in late-stage